| WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12 K Balabanian, B Lagane, JL Pablos, L Laurent, T Planchenault, O Verola, ... Blood 105 (6), 2449-2457, 2005 | 370 | 2005 |
| Stem cells and regenerative medicine: myth or reality of the 21th century JF Stoltz, N de Isla, YP Li, D Bensoussan, L Zhang, C Huselstein, Y Chen, ... Stem cells international 2015, 2015 | 207 | 2015 |
| Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002 AR Gennery, K Khawaja, P Veys, RGM Bredius, LD Notarangelo, ... Blood 103 (3), 1152-1157, 2004 | 152 | 2004 |
| Coexpression of CD40 and class II antigen HLA-DR in Graves’ disease thyroid epithelial cells GC Faure, D Bensoussan-Lejzerowicz, MC Bene, V Aubert, J Leclere Clinical immunology and immunopathology 84 (2), 212-215, 1997 | 88 | 1997 |
| Multicenter survey on the outcome of transplantation of hematopoietic cells in patients with the complete form of DiGeorge anomaly A Janda, P Sedlacek, M Hönig, W Friedrich, M Champagne, T Matsumoto, ... Blood, The Journal of the American Society of Hematology 116 (13), 2229-2236, 2010 | 84 | 2010 |
| Concise review: mesenchymal stromal/stem cells: a new treatment for sepsis and septic shock? C Laroye, S Gibot, L Reppel, D Bensoussan Stem Cells 35 (12), 2331-2339, 2017 | 81 | 2017 |
| Chondrogenic induction of mesenchymal stromal/stem cells from Wharton’s jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for … L Reppel, J Schiavi, N Charif, L Leger, H Yu, A Pinzano, C Henrionnet, ... Stem Cell Research & Therapy 6, 1-13, 2015 | 81 | 2015 |
| Mesenchymal stem cells derived from Wharton's jelly: comparative phenotype analysis between tissue and in vitro expansion T Margossian, L Reppel, N Makdissy, JF Stoltz, D Bensoussan, ... Bio-medical materials and engineering 22 (4), 243-254, 2012 | 79 | 2012 |
| Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 … V Decot, L Voillard, V Latger-Cannard, L Aissi-Rothé, P Perrier, JF Stoltz, ... Experimental hematology 38 (5), 351-362, 2010 | 78 | 2010 |
| Introduction to tissue engineering and application for cartilage engineering N De Isla, C Huseltein, N Jessel, A Pinzano, V Decot, J Magdalou, ... Bio-medical materials and engineering 20 (3-4), 127-133, 2010 | 75 | 2010 |
| Prevention of EBV‐induced B‐lymphoproliferative disorder by ex vivo marrow B‐cell depletion in HLA‐phenoidentical or non‐identical T‐depleted bone marrow … Bensoussan, Jabado, Haddad, Yvon, Moskwa, T Des Combes, Buisson, ... British journal of haematology 103 (2), 543-551, 1998 | 67 | 1998 |
| Mesenchymal stem cells derived from human bone marrow and adipose tissue maintain their immunosuppressive properties after chondrogenic differentiation: role of HLA-G WJ Du, L Reppel, L Leger, C Schenowitz, C Huselstein, D Bensoussan, ... Stem Cells and Development 25 (19), 1454-1469, 2016 | 56 | 2016 |
| Donor's age dependent proliferation decrease of human bone marrow mesenchymal stem cells is linked to diminished clonogenicity Y Li, N Charif, D Mainard, D Bensoussan, JF Stoltz, N de Isla Bio-medical materials and engineering 24 (s1), 47-52, 2014 | 53 | 2014 |
| Bone marrow vs Wharton’s jelly mesenchymal stem cells in experimental sepsis: a comparative study C Laroye, A Boufenzer, L Jolly, L Cunat, C Alauzet, JL Merlin, C Yguel, ... Stem cell research & therapy 10, 1-11, 2019 | 50 | 2019 |
| Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful … C Qian, A Campidelli, Y Wang, H Cai, V Venard, H Jeulin, JH Dalle, ... Journal of hematology & oncology 10, 1-14, 2017 | 49 | 2017 |
| Designing a three-dimensional alginate hydrogel by spraying method for cartilage tissue engineering J Tritz, R Rahouadj, N de Isla, N Charif, A Pinzano, D Mainard, ... Soft Matter 6 (20), 5165-5174, 2010 | 49 | 2010 |
| Hematologic recovery after autologous PBPC transplantation: importance of the number of postthaw CD34+ cells P Feugier, D Bensoussan, F Girard, F Alla, A Schuhmacher, ... Transfusion 43 (7), 878-884, 2003 | 48 | 2003 |
| Complete recovery from Cryptosporidium parvum infection with gastroenteritis and sclerosing cholangitis after successful bone marrow transplantation in two brothers with X … S Dimicoli, D Bensoussan, V Latger-Cannard, J Straczek, L Antunes, ... Bone marrow transplantation 32 (7), 733-737, 2003 | 46 | 2003 |
| Original approach for cartilage tissue engineering with mesenchymal stem cells J Tritz-Schiavi, N Charif, C Henrionnet, N de Isla, D Bensoussan, ... Bio-Medical Materials and Engineering 20 (3-4), 167-174, 2010 | 45 | 2010 |
| The clinical value of concomitant Epstein Barr virus (EBV)-DNA load and specific immune reconstitution monitoring after allogeneic hematopoietic stem cell transplantation M d'Aveni, L Aïssi-Rothé, V Venard, A Salmon, A Falenga, V Decot, ... Transplant Immunology 24 (4), 224-232, 2011 | 41 | 2011 |
